*Humira® is a registered trademark of AbbVie Biotechnology Ltd. and Avastin® is a registered trademark of Genentech, Inc. (USA).
1 European Medicines Agency. Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11 to 14 September 2017. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2.... [Accessed: November, 2017]
2 U.S. Food & Drug Administration. 2017. Drugs@FDA: FDA Approved Drug Products. Available at: www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process.... [Accessed: November, 2017].
3 Ramael S, et al. Similar pharmacokinetics, safety and tolerability of the Humira (adalimumab) biosimilar candidate BI 695501 administered subcutaneously via prefilled syringe (PFS) or autoinjector (AI) (VOLTAIRE-AI). Abstract presented at EULAR, Madrid, June 14-17 2017.
To read more Press Release articles, click here.